Business Segments · Total Assets
Life Sciences and Applied Markets — Total Assets
Agilent Technologies Life Sciences and Applied Markets — Total Assets increased by 1.1% to $3.14B in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 0.7%, from $3.16B to $3.14B. Over 3 years (FY 2021 to FY 2024), Life Sciences and Applied Markets — Total Assets shows relatively stable performance with a -1.7% CAGR.
Analysis
StatementSegment
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2022
Last reportedQ1 2026
Rolls up toTotal Assets
How to read this metric
An increase suggests capital expansion or investment in growth, while a decrease may indicate asset divestiture or improved asset utilization.
Detailed definition
This represents the sum of all current and non-current assets, including inventory, accounts receivable, property, plant...
Peer comparison
Commonly reported by large firms to show the capital intensity of different business segments.
Metric ID:
a_segment_life_sciences_and_applied_markets_total_assetsHistorical Data
15 periods
| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.12B | $3.12B | $3.74B | $3.75B | $3.79B | $3.89B | $3.96B | $4.00B | $3.97B | $3.92B | $3.16B | $3.14B | $3.10B | $3.11B | $3.14B |
| QoQ Change | — | -0.1% | +20.1% | +0.3% | +1.0% | +2.6% | +1.7% | +1.2% | -0.9% | -1.1% | -19.4% | -0.7% | -1.4% | +0.3% | +1.1% |
| YoY Change | — | — | — | — | +21.4% | +24.8% | +5.7% | +6.7% | +4.8% | +0.9% | -20.1% | -21.6% | -22.0% | -20.8% | -0.7% |
Range$3.10B – $4.00B
CAGR+0.2%
Avg YoY Growth-1.9%
Median YoY Growth+0.9%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Agilent Technologies's life sciences and applied markets — total assets?
- Agilent Technologies (A) reported life sciences and applied markets — total assets of $3.14B in Q3 2024.
- How has Agilent Technologies's life sciences and applied markets — total assets changed year-over-year?
- Agilent Technologies's life sciences and applied markets — total assets decreased by 0.7% year-over-year, from $3.16B to $3.14B.
- What is the long-term trend for Agilent Technologies's life sciences and applied markets — total assets?
- Over 3 years (2021 to 2024), Agilent Technologies's life sciences and applied markets — total assets has grown at a -1.7% compound annual growth rate (CAGR), from $13.12B to $12.48B.
- What does life sciences and applied markets — total assets mean?
- The total value of all assets owned and utilized by this business segment.